Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
Advertisement
Advertisement
›Stocks›REGN

ETFs with exposure to Regeneron Pharmaceuticals, Inc. (REGN)

1,258 ETFs hold Regeneron Pharmaceuticals, Inc. (REGN)
Holdings data as of May 31, 2026
6.72%
+11.56%
+3.95%
-€2.7M
-€4.2M
€10M
0.35%
VanEck Biotech ETF - USD
This ETF provides exposure to US Biotechnology Equities
6.04%
+9.81%
+8.03%
-€55K
-€6.3M
€350M
0.35%
iShares Biotechnology ETF - USD
This ETF provides exposure to US Biotechnology Equities
5.69%
+12.17%
+12.60%
+€348M
-€146M
€8.06B
0.44%
Amplify Weight Loss Drug & Treatment ETF - USD
This ETF provides exposure to Equities
5.60%
+5.42%
+1.56%
€0
+€1.3M
€3.8M
0.59%
Not rated
Invesco Nasdaq Biotechnology ETF - USD
This ETF provides exposure to US Equities
5.14%
+11.62%
+15.23%
-€814K
-€559K
€64M
0.19%
Not rated
iShares Nasdaq US Biotechnology UCITS ETF - USD
This ETF provides exposure to US Equities
Share class
Acc
USD
5.07%
+11.61%
+15.09%
+€69M
+€32M
€884M
0.35%
Mirae Asset TIGER NASDAQ BIO ETF - KRW
This ETF provides exposure to US Equities
5.07%
+13.15%
+22.05%
-€2M
-€14M
€56M
0.3%
Not rated
CAPITAL NASDAQ BIOTECHNOLOGY INDEX ETF - TWD
This ETF provides exposure to US Equities
5.07%
+13.27%
+15.92%
€0
-€16K
€8.8M
1.01%
Not rated
iShares Nasdaq US Biotechnology UCITS ETF (D) - USD
This ETF provides exposure to US Equities
Share class
Dist
USD
5.07%
+11.61%
+15.09%
+€269K
+€719K
€53M
0.35%
Invesco NASDAQ Biotech UCITS ETF Acc - USD
This ETF provides exposure to US Equities
5.07%
+11.64%
+15.11%
+€14M
-€17M
€410M
0.4%
See more results with a Trackinsight account
Get started with a free Essentials account today.
Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight